EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Device-free isolation of photoreceptor cells from patient iPSC-derived retinal organoids

Nicholas E Stone, Laura R Bohrer, Nathaniel K Mullin, Alexander Berthold, Allison T Wright, Ian C Han, Edwin M Stone, Robert F Mullins, Budd A Tucker

JCI Insight · 22.07.2025 · 10 (14)

DOI: 10.1172/jci.insight.186338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, online erschienen am 12.06.2025. Verfasst von Nicholas E Stone und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Vision Research. Hauptthemen laut MEDLINE: Organoids, Induced Pluripotent Stem Cells, Retina, Photoreceptor Cells. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, National Eye Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autologous photoreceptor cell replacement is one of the most promising strategies currently being developed for the treatment of patients with inherited retinal degenerative blindness. Induced pluripotent stem cell–derived (iPSC-derived) retinal organoids, which faithfully recapitulate the structure of the neural retina, are an ideal source of transplantable photoreceptors required for these therapies. However, retinal organoids contain other retinal cell types, including bipolar, horizontal, and amacrine cells, which are unneeded and may reduce the potency of the final therapeutic product. Therefore, approaches for isolating fate-committed photoreceptor cells from dissociated retinal organoids are desirable. In this work, we present partial dissociation, a technique that leverages the high level of organization found in retinal organoids to enable selective enrichment of photoreceptor cells without the use of specialized equipment or reagents such as antibody labels. We demonstrate up to 90% photoreceptor cell purity by simply selecting cell fractions liberated from retinal organoids during enzymatic digestion in the absence of mechanical dissociation. Since the presented approach relies on the use of standard plasticware and commercially available current good manufacturing practice–compliant reagents, we believe that it is ideal for use in the preparation of clinical photoreceptor cell replacement therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsInduced Pluripotent Stem CellsRetinaPhotoreceptor CellsCell SeparationPhotoreceptor Cells, VertebrateRetinal DegenerationHumansCell Differentiation

Stichwörter der Autor:innen

OphthalmologyStem cellsTranslationiPS cells

Autor:innen und Institutionen

  • Institute for Vision Research.
  • Department of Ophthalmology and Visual Sciences, and.
  • Department of Neuroscience and Pharmacology, Carver College of Medicine University of Iowa, Iowa City, Iowa, USA.

Förderung

  • NEI NIH HHS
  • National Eye Institute

Zitieren

APA

Stone, N. E., Bohrer, L. R., Mullin, N. K., Berthold, A., Wright, A. T., Han, I. C., Stone, E. M., Mullins, R. F., & Tucker, B. A. (2025). Device-free isolation of photoreceptor cells from patient iPSC-derived retinal organoids. JCI Insight, 10(14). https://doi.org/10.1172/jci.insight.186338

Vancouver

Stone NE, Bohrer LR, Mullin NK, Berthold A, Wright AT, Han IC, et al. Device-free isolation of photoreceptor cells from patient iPSC-derived retinal organoids. JCI Insight. 2025;10(14). doi:10.1172/jci.insight.186338

BibTeX
@article{Stone2025,
  author = {Stone, Nicholas E and Bohrer, Laura R and Mullin, Nathaniel K and Berthold, Alexander and Wright, Allison T and Han, Ian C and Stone, Edwin M and Mullins, Robert F and Tucker, Budd A},
  title = {Device-free isolation of photoreceptor cells from patient iPSC-derived retinal organoids},
  journal = {JCI Insight},
  year = {2025},
  volume = {10},
  number = {14},
  doi = {10.1172/jci.insight.186338}
}
Kostenlos starten →